Who
Rajeev Dadoo
Director
Company insider
Files Form 4 as: Director, ARS Pharmaceuticals.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 8 Nov 2022
- Last trade
- 24 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 26 Jun 2026 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 25 Jun 2025filed 27 Jun 2025 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 20 Jun 2024filed 24 Jun 2024 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 27 Jun 2023filed 28 Jun 2023 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 8 Nov 2022filed 10 Nov 2022 | SPRY ARS PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —3,009,677 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.